当前位置:首页 - 行情中心 - 欧林生物(688319) - 财务分析 - 现金流量表

欧林生物

(688319)

  

流通市值:114.33亿  总市值:114.33亿
流通股本:4.05亿   总股本:4.05亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金517,700,718.01323,403,396.72130,972,177.88641,599,397.99
  收到其他与经营活动有关的现金18,977,427.5819,773,174.735,988,547.8729,217,496.16
  经营活动现金流入小计536,678,145.59343,176,571.45136,960,725.75670,816,894.15
  购买商品、接受劳务支付的现金41,792,910.8729,983,973.9510,871,506.8639,402,719.74
  支付给职工以及为职工支付的现金81,559,405.2255,369,923.8236,455,088.02102,152,012.13
  支付的各项税费170,383,015.98107,380,478.6322,102,942.5652,136,375.9
  支付其他与经营活动有关的现金297,396,232.41220,843,121.5392,955,776.82371,632,009.02
  经营活动现金流出小计591,131,564.48413,577,497.93162,385,314.26565,323,116.79
  经营活动产生的现金流量净额-54,453,418.89-70,400,926.48-25,424,588.51105,493,777.36
二、投资活动产生的现金流量:
  收回投资收到的现金135,000,000135,000,000135,000,000200,000,000
  取得投资收益收到的现金125,136.99125,136.99125,136.99497,841.77
  处置固定资产、无形资产和其他长期资产收回的现金净额99,509.8--27,730.8
  投资活动现金流入小计135,224,646.79135,125,136.99135,125,136.99200,525,572.57
  购建固定资产、无形资产和其他长期资产支付的现金93,550,467.6124,608,881.0922,909,127.3698,811,383.26
  投资支付的现金135,000,000135,000,000135,000,000224,209,072.32
  投资活动现金流出小计228,550,467.61159,608,881.09157,909,127.36323,020,455.58
  投资活动产生的现金流量净额-93,325,820.82-24,483,744.1-22,783,990.37-122,494,883.01
三、筹资活动产生的现金流量:
  取得借款收到的现金204,000,000134,000,00020,000,000176,100,000
  筹资活动现金流入小计204,000,000134,000,00020,000,000176,100,000
  偿还债务支付的现金124,961,14039,704,32015,530,000114,720,000
  分配股利、利润或偿付利息支付的现金12,819,171.488,442,519.634,120,229.3714,716,571.59
  支付其他与筹资活动有关的现金12,969,097.0911,684,996.576,453,170.4922,263,172.24
  筹资活动现金流出小计150,749,408.5759,831,836.226,103,399.86151,699,743.83
  筹资活动产生的现金流量净额53,250,591.4374,168,163.8-6,103,399.8624,400,256.17
五、现金及现金等价物净增加额-94,528,648.28-20,716,506.78-54,311,978.747,399,150.52
  加:期初现金及现金等价物余额225,175,981.53225,175,981.53225,175,981.53217,776,831.01
  期末现金及现金等价物余额130,647,333.25204,459,474.75170,864,002.79225,175,981.53
补充资料:
  净利润--32,879,690.92-21,898,737.19
  资产减值准备--4,024,665.1-13,585,517.39
  固定资产和投资性房地产折旧-19,252,815.53-33,178,368.49
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-19,252,815.53-33,178,368.49
  无形资产摊销-691,620.93-1,531,603.18
  长期待摊费用摊销-1,602,907.24-4,105,544.24
  处置固定资产、无形资产和其他长期资产的损失----8,707.5
  财务费用-8,587,518.84-14,987,126.18
  投资损失--125,136.99--497,841.77
  递延所得税--1,922,352.32--762,860.6
  其中:递延所得税资产减少--4,090,759.19--6,698,699.4
    递延所得税负债增加-2,168,406.87-5,935,838.8
  存货的减少-1,790,196.64-9,713,212.89
  经营性应收项目的减少--99,817,678.59--84,654,805.22
  经营性应付项目的增加-27,912,333.27-75,133,339.27
  现金的期末余额-204,459,474.75-225,175,981.53
  减:现金的期初余额-225,175,981.53-217,776,831.01
  现金及现金等价物的净增加额--20,716,506.78-7,399,150.52
公告日期2026-10-302026-08-182026-04-302026-03-31
审计意见(境内)标准无保留意见
TOP↑